Summit Therapeutics Inc. (SMMT)

Healthcare · Biotechnology · NASDAQ

Summit Therapeutics Inc. (SMMT) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $11.14B and a free-cash-flow yield of -3.1%.

Market cap	$11.14B
Trailing P/E	—
FCF yield	-3.1%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live SMMT data on Nama Insights →